|
CN111632135A
|
|
Application of chimeric antigen receptor T cell targeting NKG2D in treatment of prostate cancer and medicine for treating prostate cancer
|
|
CN111363046A
|
|
Chimeric antigen receptor targeting NKG2D, chimeric antigen receptor T cell, and preparation method and application thereof
|
|
CN111909931A
|
|
Fluorescent probe, primer pair, fluorescent quantitative PCR kit and detection method
|
|
CN111910015A
|
|
Probe, primer pair, fluorescent quantitative PCR kit and method for detecting replication type lentivirus
|
|
CN111789829A
|
|
Application of U-5021 compounds in preventing and treating cytokine release syndrome caused by CAR-T therapy
|
|
CN111789868A
|
|
Application of artemisinin compound in promoting chimeric antigen receptor T cell therapy and pharmaceutical composition
|
|
CN111789834A
|
|
Application of small octreone compounds in preventing and treating cytokine release syndrome caused by CAR-T therapy
|
|
CN111789841A
|
|
Application of anopheline compound in preventing and treating cytokine release syndrome caused by CAR-T therapy
|
|
CN111789836A
|
|
Application of Pyratrione compound in cytokine release syndrome of CAR-T therapy
|
|
CN111789845A
|
|
Application of GYKI11679 compound in cytokine release syndrome of CAR-T therapy
|
|
CN110623978A
|
|
Application of chimeric antigen receptor T cell targeting CD22 in autoimmune diseases
|
|
CN110628722A
|
|
Application of chimeric antigen receptor T cell targeting CD20 in autoimmune diseases
|
|
CN110623979A
|
|
Application of chimeric antigen receptor T cell targeting CD19 in autoimmune diseases
|
|
CN110623980A
|
|
Application of chimeric antigen receptor T cell targeting CD38 in autoimmune diseases
|
|
CN110623977A
|
|
Application of chimeric antigen receptor T cell targeting BCMA (brain cell activating receptor) in autoimmune diseases
|
